Cargando…

Rational Design of CXCR4 Specific Antibodies with Elongated CDRs

[Image: see text] The bovine antibody (BLV1H12) which has an ultralong heavy chain complementarity determining region 3 (CDRH3) provides a novel scaffold for antibody engineering. By substituting the extended CDRH3 of BLV1H12 with modified CXCR4 binding peptides that adopt a β-hairpin conformation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tao, Liu, Yan, Wang, Ying, Hull, Mitchell, Schultz, Peter G., Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120998/
https://www.ncbi.nlm.nih.gov/pubmed/25041362
http://dx.doi.org/10.1021/ja5042447
_version_ 1782329161029779456
author Liu, Tao
Liu, Yan
Wang, Ying
Hull, Mitchell
Schultz, Peter G.
Wang, Feng
author_facet Liu, Tao
Liu, Yan
Wang, Ying
Hull, Mitchell
Schultz, Peter G.
Wang, Feng
author_sort Liu, Tao
collection PubMed
description [Image: see text] The bovine antibody (BLV1H12) which has an ultralong heavy chain complementarity determining region 3 (CDRH3) provides a novel scaffold for antibody engineering. By substituting the extended CDRH3 of BLV1H12 with modified CXCR4 binding peptides that adopt a β-hairpin conformation, we generated antibodies specifically targeting the ligand binding pocket of CXCR4 receptor. These engineered antibodies selectively bind to CXCR4 expressing cells with binding affinities in the low nanomolar range. In addition, they inhibit SDF-1-dependent signal transduction and cell migration in a transwell assay. Finally, we also demonstrate that a similar strategy can be applied to other CDRs and show that a CDRH2-peptide fusion binds CXCR4 with a K(d) of 0.9 nM. This work illustrates the versatility of scaffold-based antibody engineering and could greatly expand the antibody functional repertoire in the future.
format Online
Article
Text
id pubmed-4120998
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-41209982015-07-18 Rational Design of CXCR4 Specific Antibodies with Elongated CDRs Liu, Tao Liu, Yan Wang, Ying Hull, Mitchell Schultz, Peter G. Wang, Feng J Am Chem Soc [Image: see text] The bovine antibody (BLV1H12) which has an ultralong heavy chain complementarity determining region 3 (CDRH3) provides a novel scaffold for antibody engineering. By substituting the extended CDRH3 of BLV1H12 with modified CXCR4 binding peptides that adopt a β-hairpin conformation, we generated antibodies specifically targeting the ligand binding pocket of CXCR4 receptor. These engineered antibodies selectively bind to CXCR4 expressing cells with binding affinities in the low nanomolar range. In addition, they inhibit SDF-1-dependent signal transduction and cell migration in a transwell assay. Finally, we also demonstrate that a similar strategy can be applied to other CDRs and show that a CDRH2-peptide fusion binds CXCR4 with a K(d) of 0.9 nM. This work illustrates the versatility of scaffold-based antibody engineering and could greatly expand the antibody functional repertoire in the future. American Chemical Society 2014-07-18 2014-07-30 /pmc/articles/PMC4120998/ /pubmed/25041362 http://dx.doi.org/10.1021/ja5042447 Text en Copyright © 2014 American Chemical Society Terms of Use (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html)
spellingShingle Liu, Tao
Liu, Yan
Wang, Ying
Hull, Mitchell
Schultz, Peter G.
Wang, Feng
Rational Design of CXCR4 Specific Antibodies with Elongated CDRs
title Rational Design of CXCR4 Specific Antibodies with Elongated CDRs
title_full Rational Design of CXCR4 Specific Antibodies with Elongated CDRs
title_fullStr Rational Design of CXCR4 Specific Antibodies with Elongated CDRs
title_full_unstemmed Rational Design of CXCR4 Specific Antibodies with Elongated CDRs
title_short Rational Design of CXCR4 Specific Antibodies with Elongated CDRs
title_sort rational design of cxcr4 specific antibodies with elongated cdrs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120998/
https://www.ncbi.nlm.nih.gov/pubmed/25041362
http://dx.doi.org/10.1021/ja5042447
work_keys_str_mv AT liutao rationaldesignofcxcr4specificantibodieswithelongatedcdrs
AT liuyan rationaldesignofcxcr4specificantibodieswithelongatedcdrs
AT wangying rationaldesignofcxcr4specificantibodieswithelongatedcdrs
AT hullmitchell rationaldesignofcxcr4specificantibodieswithelongatedcdrs
AT schultzpeterg rationaldesignofcxcr4specificantibodieswithelongatedcdrs
AT wangfeng rationaldesignofcxcr4specificantibodieswithelongatedcdrs